SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-329889
Filing Date
2020-12-30
Accepted
2020-12-30 16:44:59
Documents
12
Period of Report
2020-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100239d8k.htm 8-K 87540
2 EX-3.1 d100239dex31.htm EX-3.1 6394
3 EX-3.2 d100239dex32.htm EX-3.2 5793
4 EX-10.1 d100239dex101.htm EX-10.1 72968
5 EX-10.2 d100239dex102.htm EX-10.2 114988
6 EX-10.3 d100239dex103.htm EX-10.3 30988
7 EX-10.5 d100239dex105.htm EX-10.5 94614
8 EX-10.6 d100239dex106.htm EX-10.6 126365
9 EX-10.7 d100239dex107.htm EX-10.7 217478
10 EX-99.1 d100239dex991.htm EX-99.1 15931
11 GRAPHIC g100239snap0001.jpg GRAPHIC 5233
12 GRAPHIC g100239snap0002.jpg GRAPHIC 3029
  Complete submission text file 0001193125-20-329889.txt   786728
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 201426364
SIC: 2834 Pharmaceutical Preparations